Atypical matters in myeloid differentiation.
Locati M, Mantovani A, Bonecchi R
Nat Immunol. 18(7):711-712. doi: 10.1038/ni.3776
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.
Mollica Poeta V
Front Immunol. 2019 Mar 6;10:379. doi: 10.3389/fimmu.2019.00379
One Clever Macrophage Checkpoint.
Mantovani A, Bonecchi R
Clin Cancer Res. 2019 Apr 1;25(11):3202-3204. doi: 10.1158/1078-0432.CCR-19-0483
Chemokines sound the alarmin: The role of atypical chemokine in inflammation and cancer.
Borroni EM
Semin Immunol. 2018 Oct 15;38:63-71. doi: 10.1016/j.smim.2018.10.005
Multiple Roles for Chemokines in Neutrophil Biology.
Capucetti A, Albano F, Bonecchi R
Front Immunol. 2020 Jul 9;11:1259. doi: 10.3389/fimmu.2020.01259
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.
Simonelli M
Neurooncol Adv. 2021 Nov 13;3(1):vdab160. doi: 10.1093/noajnl/vdab160
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
Calura E
Clin Cancer Res. 2013 Jun 13;19(15):4114-23. doi: 10.1158/1078-0432.CCR-13-0360
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Marchini S
Eur J Cancer. 2012 Aug 13;49(2):520-30. doi: 10.1016/j.ejca.2012.06.026
Mode of action of trabectedin in myxoid liposarcomas.
Di Giandomenico S
Oncogene. 2013 Nov 11;33(44):5201-10. doi: 10.1038/onc.2013.462
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.
Beltrame L
Ann Oncol. 2015 Apr 6;26(7):1363-71. doi: 10.1093/annonc/mdv164